NCT00287378View on ClinicalTrials.gov

Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab

NATerminatedINTERVENTIONAL

Enrollment

1

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

AsthmaAllergy

Interventions

DRUG

omalizumab

omalizumab as per weight and IgE

Trial Locations (1)

27599-7310

Center for Environmental Medicine, Asthma and Lung Biology at the University of North Carolina, Chapel Hill

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

Genentech, Inc.

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER